Effect of knocking down mutant p53 and re-expressing wild-type (WT) p53 in T47D Palbo-R cells on synergy and viability to the RP-6306 and gemcitabine combination
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: